Jun 16, 2026 08:02AM
Jun 16, 2026 08:02AM
Jun 1, 2026 08:47AM
Jun 1, 2026 08:46AM
May 28, 2026 04:00PM
May 28, 2026 04:00PM
May 26, 2026 07:03AM Outlook Therapeutics wins FDA appeal for eye drug application
May 26, 2026 07:00AM
May 18, 2026 06:08AM
May 15, 2026 04:05PM
Apr 23, 2026 04:05PM
Apr 23, 2026 04:05PM
Apr 22, 2026 08:30AM
Apr 22, 2026 08:30AM Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Apr 21, 2026 09:05AM
Apr 21, 2026 09:05AM
Apr 7, 2026 08:56AM
Apr 7, 2026 08:50AM
Apr 7, 2026 08:50AM
Mar 25, 2026 04:05PM
Mar 25, 2026 04:05PM Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Mar 23, 2026 05:30PM
Mar 23, 2026 05:30PM
Mar 16, 2026 08:06AM
Mar 16, 2026 08:05AM
Mar 5, 2026 04:16PM Outlook Therapeutics meets with FDA on bevacizumab drug approval
Mar 5, 2026 04:15PM
Feb 17, 2026 08:05AM
Feb 11, 2026 08:45AM
Feb 11, 2026 08:45AM
Jan 5, 2026 06:41AM
Jan 2, 2026 07:02AM
Dec 31, 2025 04:15PM Outlook Therapeutics receives FDA rejection for eye drug application
Dec 31, 2025 04:15PM
Dec 19, 2025 08:05AM
Dec 19, 2025 08:05AM
Nov 13, 2025 08:31AM
Nov 13, 2025 08:30AM
Nov 3, 2025 08:35AM
Nov 3, 2025 08:35AM Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
Sep 30, 2025 06:54AM
Sep 29, 2025 04:03PM
Sep 29, 2025 08:45AM
Sep 29, 2025 08:45AM
Sep 2, 2025 08:35AM
Sep 2, 2025 08:35AM
Aug 29, 2025 06:51AM H.C. Wainwright Downgrades Outlook Therapeutics Incs. (OTLK) to Neutral
Aug 28, 2025 06:53AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All